About

BeOne Medicines is a global oncology company focused on discovering, developing, and commercializing innovative cancer treatments. They have a broad pipeline across hematologic malignancies and solid tumors, utilizing internal research and collaborations. The company aims to make transformative medicines more accessible to patients worldwide.

Key facts

At-a-glance profile data

Website: beonemedicines.com
Headquarters: Basel, Switzerland
Cheque size: $108M to $108M
Sector focus: Oncology
Biotechnology
Pharmaceuticals

Add first review